228 related articles for article (PubMed ID: 37321074)
1. Stereotactic body radiation therapy and thermal ablation for treatment of NSCLC: A systematic literature review and meta-analysis.
Laeseke P; Ng C; Ferko N; Naghi A; Wright GWJ; Zhang Y; Laidlaw A; Kalsekar I; Laxmanan B; Ghosh SK; Zhou M; Szapary P; Pritchett M
Lung Cancer; 2023 Aug; 182():107259. PubMed ID: 37321074
[TBL] [Abstract][Full Text] [Related]
2. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer (NSCLC): a systematic review and meta-analysis.
Chan MV; Huo YR; Cao C; Ridley L
Eur Radiol; 2021 Jul; 31(7):5421-5433. PubMed ID: 33449192
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial.
Dupuy DE; Fernando HC; Hillman S; Ng T; Tan AD; Sharma A; Rilling WS; Hong K; Putnam JB
Cancer; 2015 Oct; 121(19):3491-8. PubMed ID: 26096694
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis.
Bi N; Shedden K; Zheng X; Kong FS
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1378-1390. PubMed ID: 27479723
[TBL] [Abstract][Full Text] [Related]
6. Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases.
Di Martino M; Rompianesi G; Mora-Guzmán I; Martín-Pérez E; Montalti R; Troisi RI
Eur J Surg Oncol; 2020 May; 46(5):772-781. PubMed ID: 31862133
[TBL] [Abstract][Full Text] [Related]
7. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
Tan W; Deng Q; Lin S; Wang Y; Xu G
Int J Hyperthermia; 2019; 36(1):264-272. PubMed ID: 30676100
[TBL] [Abstract][Full Text] [Related]
8. Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis.
Zhang R; Kang J; Ren S; Xing L; Xu Y
Ann Transl Med; 2022 Jan; 10(2):104. PubMed ID: 35282118
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.
Kim N; Cheng J; Jung I; Liang J; Shih YL; Huang WY; Kimura T; Lee VHF; Zeng ZC; Zhenggan R; Kay CS; Heo SJ; Won JY; Seong J
J Hepatol; 2020 Jul; 73(1):121-129. PubMed ID: 32165253
[TBL] [Abstract][Full Text] [Related]
10. A Meta-Analysis of Clinical Outcomes After Radiofrequency Ablation and Microwave Ablation for Lung Cancer and Pulmonary Metastases.
Yuan Z; Wang Y; Zhang J; Zheng J; Li W
J Am Coll Radiol; 2019 Mar; 16(3):302-314. PubMed ID: 30642784
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous thermal ablation for stage IA non-small cell lung cancer: long-term follow-up.
Narsule CK; Sridhar P; Nair D; Gupta A; Oommen RG; Ebright MI; Litle VR; Fernando HC
J Thorac Dis; 2017 Oct; 9(10):4039-4045. PubMed ID: 29268414
[TBL] [Abstract][Full Text] [Related]
12. Microwave ablation treatment for medically inoperable stage I non-small cell lung cancers: long-term results.
Ni Y; Huang G; Yang X; Ye X; Li X; Feng Q; Li Y; Li W; Wang J; Han X; Meng M; Zou Z; Wei Z
Eur Radiol; 2022 Aug; 32(8):5616-5622. PubMed ID: 35226157
[TBL] [Abstract][Full Text] [Related]
13. Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: Meta-analyses and a systematic review.
Lee J; Shin IS; Yoon WS; Koom WS; Rim CH
Radiother Oncol; 2020 Apr; 145():63-70. PubMed ID: 31923711
[TBL] [Abstract][Full Text] [Related]
14. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.
Xu Y; Shen Q; Wang N; Wu PP; Huang B; Kuang M; Qian GJ
Chin J Cancer; 2017 Jan; 36(1):14. PubMed ID: 28103953
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation
Li M; Xu X; Qin Y; Zhang P; Shen C; Xia Q; Fan L
J Cancer; 2021; 12(10):3057-3066. PubMed ID: 33854605
[No Abstract] [Full Text] [Related]
16. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer.
Sher DJ; Wee JO; Punglia RS
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e767-74. PubMed ID: 21300476
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous thermal ablation for primary hepatocellular carcinoma: A systematic review and meta-analysis.
Chinnaratha MA; Chuang MY; Fraser RJ; Woodman RJ; Wigg AJ
J Gastroenterol Hepatol; 2016 Feb; 31(2):294-301. PubMed ID: 26114968
[TBL] [Abstract][Full Text] [Related]
18. Ablation techniques in non-small cell lung cancer patients: experience of a single center.
Botsa E; Thanou I; Tavernaraki K; Thanos L
Hippokratia; 2022; 26(3):105-109. PubMed ID: 37324042
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of microwave ablation versus radiofrequency ablation in the treatment of colorectal liver metastases: A systematic review and meta-analysis.
Tang Y; Zhong H; Wang Y; Wu J; Zheng J
Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102182. PubMed ID: 37479137
[TBL] [Abstract][Full Text] [Related]
20. Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer.
Tramontano AC; Cipriano LE; Kong CY; Shepard JA; Lanuti M; Gazelle GS; McMahon PM
AJR Am J Roentgenol; 2013 May; 200(5):1020-7. PubMed ID: 23617484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
